“In the Trump administration’s filings, the Justice Department asked a Texas federal district court on March 13 to either stay or dismiss Florida and Texas challenges to mifepristone, arguing that the Food and Drug Administration (FDA) is reviewing the drug’s safety. The federal filing follows the administration’s active attempts to stay or dismiss similar challenges to mifepristone in Louisiana, Missouri, Idaho and Kansas.” - Baptist Press
- About
- Forum
- Account
